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Purpose: The role of infrainguinal arterial reconstructive surgery for claudication is 
controversial. We reviewed the results of femorotibial bypass procedures performed in a 
select group of patients with disabling claudication i an attempt to define a role for this 
aggressive approach. 
Methods: Data were retrieved from the vascular egistry, and hospital records were 
obtained for all patients undergoing femorotibial reconstruction for disabling claudication 
during the past 16 years at Brigham and Women's Hospital. FoUow-up interviews were 
obtained to assess overall health, walking impairment, functional status, and patient 
satisfaction. 
Results: During a 16-year period a total of 57 tibial reconstructions were performed in 53 
patients for claudication (5% of all infrainguinal vein reconstructions). Autogenous vein 
conduit was used in all cases, most of which (70%) involved the greater saphenous vein 
in situ. Distal anastamoses were to the tibioperoneal trunk (12%), anterior tibial (18%), 
posterior tibial (47%), and peroneal (213%) arteries. Major complications occurred in 9°/o, 
and no perioperative deaths occurred. Overall 5-year survival was 54% --. 15%, and no 
major amputations were performed. Cumulative primary and secondary graft patency at 
5 years were 81% + 6% and 86% + 5°/6, respectively. Patency rates were significantly 
better than those achieved in a concurrent series oftibial bypasses for limb salvage and were 
equivalent to those achieved with femoropopliteal bypass for claudication. Interviewed 
patients reported improved walking distance, reduced claudication, and a high degree of 
overall satisfaction with their operation. 
Conclusion: Results obtained with femorotibial bypass performed for claudication were 
superior to those obtained for limb salvage and were equivalent to hose obtained with 
femoropopliteal bypass for claudication. The results obtained in this highly selected cohort 
suggest that patients at low risk with significant functional impairment from claudication, 
available autogenous vein, and suitable tibial outflow to the ischemic muscular bed can be 
offered revascularization with the expectation ofdurable long-term results. (J VAsc SURG 
1995;21:873-81.) 
Improved long-term treatment of patients with 
atherosclerotic cardiovascular disease has resulted in 
From the Division f Vascular Surgery, Brigham & 'Women's 
Hospital and Harvard Medical School, Boston. 
Presented at the Twenty-first Annual Meeting of the New England 
Society for Vascular Surgery, Newport, R.I., Sept. 29-30, 1994. 
Reprint requests: Anthony D. Whittemore, MD Brigham and 
Women's Hospital, 75 Francis Street, Boston, MA 0:2115. 
~Present address: Division of Vascular Surgery, Yale University 
School of Medicine, New Haven CT 06520. 
Copyright © 1995 by The Society for Vascular Surgery and 
International Society for Cardiovascular Surgery, Non:h Ameri- 
can Chapter. 
0741-5214/95/$3.00 + 0 24/6/63675 
a decreasing disease-specific mortality rate in recent 
years.~ Concomitant advances in preoperative assess- 
ment and correction of cardiac disease, anesthetic 
management, and surgical technique have combined 
to improve the safety and efficacy of vascular surgical 
procedures, As a result reconstructive surgical pro- 
cedures for arterial occlusive disease are now being 
routinely performed on older patients, and bypass 
grafts to the tibial or pedal vessels are commonly used 
with durable success. 
Little debate xists among vascular surgeons 
concerning the appropriateness of intervention for 
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Table I. Patient demographics and distribution of risk factors 
This series (n = s3) FP/CL4UD (n = 26~) FT/LS (n = 369) 
M : F 44 : 9 172 : 89 241 : 128 
Age-mean (range) 66 (44-85) 63 (32-82) 68 (26-97) 
Risk factors-No. (%) 
Smoking* 33 (58) 198 (76) 186 (50) 
Diabetes mellitus 14 (25) 49 (19) 180 (49) 
Hypertension 40 (70) 146 (56) 206 (56) 
Coronary artery disease 25 (44) 129 (49) 174 (47) 
Previous CABG 4 (7) 18 (7) 40 (11) 
COPD 7 (12) 34 (13) 45 (12) 
Kidney failure 3 (5) 9 (3) 25 (7) 
Baseline ABI 
Mean 0.56 0.58 0.54 
Median 0.57 0.56 0.44 
M, Male; F, female; C£ZlBG, coronary artery bypass grafting; COPD, coronary obstructive pulmonary disorder;ABI, ankle/brachial index. 
*Defined as positive if patient reported smoking within 1 year before procedure. 
Table II. Proximal and distal sites 
of anastamoses 
No. % 
Proximal 
Common femoral 44 77 
Proximal SFA 9 16 
Distal SFA 3 5 
Profimda 1 1.8 
Distal 
Tibioperoneal trunk 7 12 
Posterior tibial 27 47 
Peroneal 13 23 
Anterior tibial 10 18 
SFA, Superior femoral artery. 
patients with lower extremity ischemia of limb- 
threatening severity. In contrast, numerous reports 
have documented the benign natural history of 
intermittent claudication and have formed the basis 
for a conservative approach to this symptom 
complex.24 Nonetheless aortofemoral reconstruction 
is routinely used for daudication both because of the 
excellent long-term patency rates achieved and the 
perception that patients with claudication who have 
aortoiliac disease may be more likely to progress to 
critical ischemia. 2's A role for femoropopliteal bypass 
grafting in patients with severe claudication, al- 
though more controversial, is supported by the low 
operative risk and excellent long-term results ob- 
tained in modern series, s7 
With increasing confidence in the results of 
femorotibial bypass, preferentially performed in our 
institution with the in situ technique, we have 
liberally used this procedure as part of an aggressive 
approach to limb salvage. During the last 16 years 
we have also performed tibial bypass on a small subset 
of patients with disabling claudication and corn- 
bined superficial femoral and popliteal occlusive 
disease. In an effort to determine a role for tibial 
bypass in the management of severe claudication, we 
undertook a retrospective r view of this select group 
of patients. 
PATIENTS AND METHODS 
A total of 53 patients who underwent 57 femo- 
rotibial reconstructions for claudication from 1977 
to 1993 were identified, and pertinent data were 
retrieved from the vascular egistry and hospital 
records. Two other groups of patients undergoing 
reconstruction i  our institution during the same 
time period (1976 to 1991) were analyzed for 
comparison with the patients in this series: the 
FP/CLAUD group consisted of 261 femoropopliteal 
vein bypasses performed in 220 patients for claudi- 
cation, and the FT/LS group consisted of 369 
femorotibial vein grafts performed in332 patients for 
limb salvage indications. Patient demographics and 
distribution of associated risk factors are shown in 
Table I. Nine of the 57 reconstructions were second- 
ary procedures, and all were performed with autog- 
enous vein conduit (in situ saphenous vein -40 
(70%); reversed saphenous vein, 12 (21%); arm 
vein, 2 (2.7%); composite vein, 2 (2.7%); and lesser 
saphenous vein, 1 (1.8%). Most grafts originated at 
the common femoral or proximal superficial femoral 
artery (Table II). Distal anastamoses were con- 
structed to the tibioperoneal trtmk in 7 (12%) cases, 
anterior tibial in 10 (18%), posterior tibial in 27 
(47%), and peroneal artery in 13 (23%). 
Preoperative evaluation included segmental 
Doppler pressures and pulse volume recordings; 
baseline hemodynamic indexes are shown in Table I. 
All patients underwent contrast arteriography before 
}'OURNAL OF vASCULAR SURGERY 
Volume 21, Number 6 Conte et al. 875 
Table III. Response scales used in outcome survey 
Item No. levels Description 
Overall health 1-5 
Maximal walking distance 1-6 
Causes of walking impairment: 
Claudication 1-5 Very much-none 
Joint pain/stiffness 1-5 . Very much-none 
Chest pain/SOB 1-5 Very much-none 
Weakness in legs 1-5 Very much-none 
Role functioning/independence 1-5 Excellent-poor 
Recommended this operation to others? Yes/No 
Excellent-poor 
Blocks > 5, 2-5, 1-2, 1/2-1, < 1/2, rest pain 
SOB, Shortness of breath. 
operation. Patients were monitored after the opera- 
tion at regular intervals, usually every 3 to 4 months 
for the first 2 years and at 6-month intervals 
thereafter. Graft patency was assessed by physical 
examination, segmental limb pressures, pulse volume 
recordings, and in recent years by duplex ultrasonog- 
raphy. A decrease in overall graft velocity o less than 
0.4 m/see, focal increased velocity ratio of 2.5, or 
decrease in ankle/brachial index of greater than 0.10 
were criteria for repeat arteriography to assess the 
graft even in patients without symptoms. 8 
Follow-up telephone interviews were obtained in 
21 of 24 surviving patients, An eight-item question- 
naire was designed incorporating aspects of other 
previously published health surveys (SF-36 health 
status survey, 9 PAD walking impairment question- 
naire:°). Patients were asked to rate their overall 
health, maximal walking distance, causes of walking 
impairment, and functional independence b fore the 
operation and at the time of follow-up with the scales 
summarized on Table III. As a measure of overall 
satisfaction, patients were also asked whether they 
would recommend the operation to another indi- 
vidual under identical circumstances. All of the 
interviews were conducted by either one of the 
authors (M. S. C.) or an experienced vascular nurse 
clinician. 
Graft patency, amputation rate, and survival wcrc 
determined by actuarial life table analysis and were 
reported in accordance with the guidelines uggested 
by the Ad Hoc Committee on Reporting Stan- 
dards. H Rates were expressed as mean _+ SE deter- 
mined by the Greenwood method. 12 Cumulative 
palliation rate was defined as the proportion of 
patients both alive and with functioning rafts at each 
time point. :3 Statistical comparisons between life 
table curves were made with the Mantel-Cox log rank 
test of significance. Preoperative and postoperative 
hemodynamic ndexes were compared by a paired 
t test statistic. 
RESULTS 
No deaths occurred in the 30 days after the 
operation. Major complications occurred in five (9%) 
patients including myocardial infarction in one, renal 
failure in one, pulmonary embolism in one, and 
cerebrovascular events in two. Follow-up evaluation 
was complete for 45 grafts for a mean period of 30 
months and a range of up to 4170 days. Hemody- 
namic (ankle/brachial) indexes improved significantly 
from a preoperative mean of 0.56 + 0.15 to a 
postoperative mean of 0.97 + 0.23 (p < 0.0001, 
paired Student's t test). 
Survival curves for the three groups of patients are 
illustrated in Fig. 1. Patients undergoing tibial bypass 
for claudication demonstrated a survival rate of 
81% + 9% at 3 years and 54% + 15% at 5 years. 
This observed 5-year survival was not significantly 
different from that of the FT/LS group (61% + 
4%). In contrast, survival for the FP/CLAUD group 
at 5 years was 76% + 3%, a difference that ap- 
proached statistical significance (p < 0.055 com- 
pared with present series). Of the 12 deaths in this 
series six were due to cardiovascular causes (four 
myocardial infarction, one cardiovascular ccident, 
one congestive heart failure), one to multiorgan 
failure, and five from unknown causes. 
Primary and secondary graft patency for all three 
groups are illustrated in Figs. 2, 3, and Table 4. In 
this series a total of nine grafts sustained primary 
failure, five of which occurred in the first postoper- 
ative month. Two of the nine grafts were revised 
while still patent both at the 6- and 12-month 
intervals. Three grafts with thrombosis were revised 
in the first month, and all three revisions subse- 
quently failed by 6 months. Overall primary and 
secondary patency at 5 years were 81% + 6% and 
86% + 5%, respectively. These results were not 
significantly different from those achieved in the 
FP/CLAUD group (74% _+ 3%, 81% _+ 3%, pri- 
mary and secondary patency at 5 years) but were 
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Table IV. Comparative 5-year esults of inftaingttinal vein bypass! 1976-1993 
This series FT/LS FP/CLA UD 
(n = 57grafts) (n = 369 grafts) (n = 261 grafts) 
Survival (%) 54 + 15 61 + 4 78 -+ 3" 
Limb loss (%) 0 25 + 2~ 3 -+ i t  
1 ° Patency (%) 81 _+ 6 51 -+ 4t  74 _+ 3 
2 ° Patency (%) 86 + 5 61 _+ 4? 81 + 3 
Cumulative palliation (3 yrs) (%) 71 _+ 9 - 78 -+ 3 
*p < 0.055 compared with this series. 
tp < 0.01 compared with is series. 
Table V. Changes in health perception before and after operation 
Improved-I Improved-2 Improved-3 Worse-I Worse-2 Worse-3 
level levels levels level levels levels Unchanged 
Overall health status 3 l 1 3 1 0 12 
Maximal walking dis- 2 7 6 2 0 0 4 
tance 
Impairment of walking 
Claudication 1 4 10 1 0 0 6 
loint pain/stiffness 0 0 0 1 2 i 17 
Chest pain/SOB 0 0 0 0 0 0 21 
Weakness in legs 0 0 0 1 0 0 20 
Role functioning/in- 7 4 1 0 0 0 9 
dependence 
Would recommend Yes 18 No 3 
procedure to others? 
SOB, Shormess of breath. 
significantly better than those achieved for patients in 
the FT/LS group (51% + 4%, 61% _+ 4%, primary 
and secondary patency at 5 years, p < 0.001). 
The 5-year amputation rates observed for the 
FT/LS group (25% + 2%) and the FP/CLAUD 
group (3% _+ 1%) were both significantly different 
(p < 0.01) from that in the present series, in which 
no limbs were lost (note: 12 of 57 limbs in this series 
were lost to follow-up). 
Cumulative palliation was defined as the presence 
of a patent graft in a surviving patient at each time 
point and was analyzed by the life table method. 
Successful palliation was achieved in 71% + 8% of 
patients in this series at 3 years compared with 
78% _+ 3% of patients in the FP/CLAUD group at 
the same time point. These data are graphically 
represented in Fig. 4. 
Results of follow-up interviews are summarized 
in Table V. Marked improvement in maximal walk- 
ing distance was observed, with 15 of 21 respondents 
reporting increased istance achieved; 13 of these 
improved by 2 or more rating levels. Two patients 
reported eterioration i  walking distance compared 
with their preoperative state; in one case this 
deterioration was caused by worsening arthritis, and 
in the other it was caused by claudication in the 
contralateral limb. The degree to which walking was 
impaired specifically by claudication was decreased in 
15 patients, with 10 patients improving by 3 or more 
scale levels. Role fianctioning and independence were 
improved in 12 patients and unchanged in nine; no 
patients reported deterioration on this item. An 
impressive 86% (18 of 21) expressed overall satis- 
faction with their operation and would recommend it 
to other individuals in the same circumstances. 
Overall health status and degree of walking impair- 
ment caused by comorbid conditions (arthritis, 
cardiopulmonary disease, general debility) did not 
change appreciably for the interviewed patients. 
DISCUSSION 
The traditional conservative approach to the 
treatment of intermittent claudication is based in 
large part on data from natural history studies 
published in the era before modern arterial recon- 
structive surgical procedures. 24These studies docu- 
mented the low risk of limb loss (approximately 1% 
per year) and significant mortality rate (approxi- 
mately 5% per year) incurred by this population of 
patients. More recent studies have sought o define 
the risk factors for progression to critical ischemia in 
patients having both subjective and objective (i.e., 
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noninvasive testing) evidence of arterial occlusive 
disease. 1416 These data reveal progression to critical 
ischemia in 17% to 41% of patients and confirm the 
previous observations of mortality resulting primar- 
ily from cardiovascular causes. Risk factors identified 
for progression to critical ischemia have included 
continued smoking, ~4,~sa7 diabetes mellims, 18-2° 
ankle/brachial index (initial, 16 decrease after exer- 
cise, 16 or decrease on serial examinationl4), and the 
presence of multilevel disease, is The prognostic 
significance of level of disease remains unclear, with 
some authors attributing a higher risk to the aor- 
toiliac segment z,3 and others indicating a less favor- 
able prognosis for patients with predominantly distal 
disease. 4,zl At this time rigorous clinical criteria for 
predicting the likelihood of progression to critical 
ischemia for a given patient with claudication have 
not been established. 
The results reported from selected series of 
arterial reconstructive procedures in patients with 
claudication are summarized in Table V~. 5-7'13'22-26 In 
addition to standard limb salvage and patency rates; 
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the concept of cumulative palliation is useful in 
assessing the likelihood of deriving benefit from an 
intervention. In this series cumulative successful 
palliation was obtained in 71% and 51% of patients 
at 3 and 5 years, respectively; these rates are not 
significantly different from those observed in the 
FP/CLAUD group and are virtually identical to those 
previously reported for femoropopliteal bypass in 
patients with claudication. 13 By all of these measures, 
the results obtained in this series of bypasses to the 
tibial level clearly compare quite well with those 
reported for other more commonly accepted proce- 
dures for claudication. 
Analysis of patient survival at late time points in 
this series was hampered by small patient numbers 
and incomplete follow-up. Nonetheless a marked 
trend of poorer survival was noted for patients with 
claudication undergoing tibial bypass as opposed to 
femoropopliteal bypass, a difference that very nearly 
reached statistical significance. These data suggest 
that patients with clandication are a heterogeneous 
group with respect to longevity. The observation of 
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Table VI. Comparative r sults of vascular reconstructions i  patients with claudication 
Survival Secondary patency 
Patients with 5 Years 10 Years 5 Years 10 Years 
No. claudication (%) (%) (%) (%) (%) 
Limb loss > 5 yrs 
(%) 
Aortofemoral 
Szilagyi et al. 24 1647 65 
Brewster et al. 25 582 56 
Martinez et alY 376 72 
Nevelsteen et al. 26 352 42 
Crawford et al. 27 719 100 
Femoropopliteal 
Kent et al.5 167 100 
Taylor et al. 6 88 100 
Donaldson et al.7 240 32 
Sladen et al.13 100 100 
This series 57 100 
59 33 85 80 6.5 
- - 88 75 - 
7 9  48 88 78 4 
65 37 80 62 8 
76 56 87 81 3 
88 - 78* 2.4 
67 - 83t  
70 - 865 2.2 
79 84 79 5 
54 86 0 
*Reported as primary patency only. 
tPatency results not analyzed separately for 
SPatency results not analyzed separately for 
patients with claudication (31% of total series). 
patients with claudication (32% of total series). 
increased long-term ortality for the patients under- 
going tibial bypass concurs with the results of other 
authors who have noted the correlation of increasing 
mortality with more distal evels of arterial occlusive 
disease in the lower extremities. = 
The functional assessment surveys performed in 
this study were intended to explore patient percep- 
tions of their outcome from operation. The methods 
used clearly suffer from a number of sources of bias 
(retrospective, telephone interviews, time interval 
from procedure to interview as long as 3 years) and 
are not presented as a standard for outcome assess- 
ment in vascular surgical procedures. We have previ- 
ously reported our experience with more exhaustive, 
validated outcome assessment instruments per- 
formed in patients undergoing elective vascular surgi- 
cal procedures in a prospective manner (unpublished 
data, January 1995). These limitations notwithstand- 
ing, the results of our interviews are striking in their 
uniformity of outcome with respect o improved 
walking, maintenance of independence, and overall 
satisfaction. At the minimum they provide important 
subjective information on the effects of operation for 
claudication that are not reflected in standard pa- 
tency, limb loss, and survival curves. 
The low frequency with which we have per- 
formed tibial bypass for claudication ( < 4 procedures 
per year) is testimony to the difficulty in selecting 
patients likely to benefit from a surgical procedure. 
Patients with significant cardiopulmonary, neuro- 
logic, musculoskeletal, or other conditions that are 
likely to impair their functional capacity or severely 
limit survival would not be considered candidates for 
reconstruction u less they progress to critical isch- 
emia. Conversely, our data suggest that patients at 
low risk who are severely limited by claudication 
should be considered for reconstruction, even if 
preoperative arteriography dictates the need for a 
distal anastomosis at the tibial level. Incomplete 
availability of the preoperative angiograms in this 
retrospective study precludes analysis of rtmoff 
scores. Nonetheless the authors would consider the 
presence of a continuous tibial vessel to the ankle as 
minimal angiographic criteria for considering this 
procedure. 
Despite the significant limitations noted previ- 
ously, this series makes ome important observations. 
Bypass grafts to the tibial level with autogenous vein, 
when performed for claudication, have patency rates 
equivalent to those of femoropopliteal bypass and 
significantly better than those obtained with tibial 
bypass for limb salvage. In most patients improved 
walking distance and refief from claudication is 
reliably achieved. On the other hand, patient survival 
may be more closely linked to the level of arterial 
occlusive disease. Taken together, these results high- 
light the therapeutic potential and the hazards of 
optimal patient selection i  considering an aggressive 
approach to severe claudication. 
We gratefillly acknowledge the assistance of Ms. Julie 
Lombara for data retrieval and statistical nalysis. 
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DISCUSSION 
Dr. James Menzoian (Boston, Mass.). It seems very 
unusual to me that 42% of your patients with clandication 
are nonsmokers. Could you comment on this low incidence 
of smoking in your patients? 
I am curious about your health status survey, and I 
caution you about some of your conclusions, because you 
modified a tool, the SF-36. You sort of redesigned it on 
your own, and you selected out eight questions. Research- 
ers in this area tell me that you now have an invalidated 
tool, and so you must be careful of your conclusions. 
In addition, your questionnaire was administered at
very variable time periods, sometimes up to 3 years after the 
operation. On the subject of the questionnaire, I noticed 
that the maximum walking distance of the 21 patients 
whom you surveyed, two were worse and four were 
unchanged. I am curious, were these worse or unchanged 
results in patients with occluded grafts, or were these 
patients with some comorbid events like arthritis? It also 
begs another question. Do you think if one does femo- 
rotibial reconstructions for claudication, and if these grafts 
fail, are the patients back to baseline, orare they worse off?. 
I am also curious about the pattern of the atheroscle- 
rotic disease. Who are these patients? To me it seems an 
unusual pattern of atherosclerosis with superior femoral 
artery occlusion, popliteal occlusion, and proximal tibial 
occlusion. It sounds like they are diabetics, yet only 25% of 
your patients had diabetes. 
The other interesting thing you point out in your article 
is that the 5-year survival of these patients is about 50%, 
which is similar to patients in whom femorotibial recon- 
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struction was done for limb salvage and sounds very 
dissimilar to the usual patients with claudication. 
I think these are very excellent results. You have an 
implied conclusion that maybe we ought to stop apologiz- 
ing for operating on patients with claudication, but I think 
if your results can be as excellent as this-81% 5-year 
patency, no amputations, no mortality-we should prob- 
ably stop apologizing. 
My final question is, who should get this operation? 
You talk about optimal patient selection. You obviously 
have been very selective, because you collected 53 patients 
during a 16-year period. Who are these patients? How were 
they selected, and how do you evaluate them? Because their 
5-survival is 50%, they really are sort of like patients 
undergoing limb salvage, so should it be that the preop- 
erative valuation of these patients from a cardiac point of 
view should be different? 
Dr. Michael S. Conte. I do not have an explanation 
why only 58% of the patients were smokers, but I agree 
with you this is most commonly a problem that we see in 
smokers. 
In terms of the outcome assessment surveys, we 
modified the previously published surveys mostly because 
they had to be conducted via telephone by an interviewer, 
because they were already so complicated and the patients 
were so far out from operation at the time of interview. We 
tried to reduce the total number of items to keep it as simple 
as possible; however, we do concede that there are 
limitations in regard to this method and merely present it 
as a means of illustrating an attempt at assessment of 
functional outcome under these constraints. 
In regards to the two patients who got worse after 
reconstruction-actually onewas due to arthritis, and the 
other had worsening clandication i the contralateral limb. 
In the four patients who were unchanged, it is not clear 
what the reason for that was. 
The pattern of disease is one you might expect o see 
more often in diabetics; however, the arteriogram that I 
showed illustrated, I think, some of the point of the study; 
that is, rather than choosing a below-knee popliteal vessel 
that is diseased for reconstruction, we would opt to go to 
a proximal tibial vessel that is disease-free, and that may 
account for some of the strange pattern of disease that is 
evident. 
The survival is more similar to the patients undergoing 
limb salvage operations, and again this makes the optimal 
patient selection critical. 
I do not have the answer to that which is the golden 
question: how do we select hese patients? Patients who 
have significant cardiopulmonary disease, arthritis, or other 
conditions that might affect not only their survival but also 
their ability to gain benefit from the surgery-we would 
opt to be more conservative and wait until they get into a 
limb salvage situation. However, we believe that patients 
who are otherwise good candidates and have significant 
claudication should not be deferred on the basis of an 
arteriogram that shows popliteal occlusion and the need to 
move down to the tibial level. 
Dr. David Brewster (Boston, Mass.). Although I 
agree with most of your conclusions, I wonder whether you 
can comment a bit on how one defines or objectively 
quantifies "disabling claudication." Even with your out- 
standing results, I think we still need to be cautious about 
recommending tibial bypass for only moderate claudication 
symptoms. 
Second, given the obvious importance of a satisfactory 
vein and the appropriate emphasis your group has so long 
placed on autogenous conduits for distal bypass, can you 
elaborate on how the surgeon can tell before the operation 
that a good vein is likely to be present and can therefore 
more confidently recommend distal bypas  for claudication 
alone? 
Finally, if the ipsilateral greater saphenous vein is not 
available, are alternative vein sources reliable enough to 
justify distal bypass for claudication? 
Dr. Conte. Thank you, Dr. Brewster. One of the 
limitations of our retrospective review was an inability to 
precisely define what constituted isabling clandication i  
all of these patients based on reviewing the records. It has 
not been routine in our practice to use exercise treadmill 
testing. In general, based on the low rate at which these 
procedures are performed, the conservative nature of the 
surgeons involved is illustrated. The only comment I can 
make in terms of trying to shed some light on this is that 
when we did our surveys, 10 of the patients reported that 
their preoperative walking distance was less than one block, 
and the remainder reported this distance to be between one 
and two blocks, although interviews were performed as 
long as 3 years after the time of operation. In addition, the 
preoperative ankle brachial index of 0.56 was shown and 
gives some indication of the severity of disease. 
In terms of the conduit used, obviously we favor 
autogenous conduit and our preferred reconstruction 
technique to the tibial level is the in situ greater saphenous 
vein. We do not routinely use vein mapping if it looks like 
there is ipsilateral or contralateral greater saphenous vein; 
however, if it looks like there has been previous harvesting 
of both saphenous veins, we would try to vein map the 
lesser saphenous and arm veins in considering reconstruc- 
tive conduits. 
